is semaglutide being removed from the market Novo cuts GLP-1 prices 70%, but revenue could grow in 2026 The FDA announced plans to

This assessment considers your hunger levels, side effects, weight loss rate, and your personal goals

However, the triple-hormone receptor agonism of retatrutide may bring additional benefits, potentially leading to more improvements in these parameters

Many patients blame themselves for lack of discipline when the real issue is that their metabolism is underpowered

This article outlines what is currently known, the potential risks, the UK regulatory position, and how to have informed conversations with your diabetes care team

Semaglutide GLP-1 for weight loss is typically administered once a week

Recently, LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results) study shows that GLP-1 analogue liraglutide treatment reduces the rates of cardiovascular events and death in patients with type 2 diabetes 9